Overview: HBV DNA Quantitative PCR TestIntroduction: The HBV DNA Quantitative PCR Test quantifies hepatitis B viral DNA to assess treatment response, preventing liver failure. Aligned with 2023 AASLD guidelines, it uses PCR for high sensitivity, aiding in infectious disease screening. This test is critical for guiding antiviral therapy adjustments, monitoring treatment efficacy, and improving outcomes in virology for patients with chronic hepatitis B.
Other Names: HBV DNA Quant Assay, Hepatitis B Viral Load Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: HBV DNA quantification began in the 1990s with PCR development. Quantitative PCR assays improved in the 2000s, enhancing treatment monitoring.
Purpose: Assesses hepatitis B treatment response, guides antiviral therapy, and quantifies HBV DNA in patients to prevent liver failure.
Test Parameters: 1. HBV DNA (Quantitative)
Pretest Condition: No fasting required. Collect whole blood, plasma, or serum at any time. Report history of hepatitis B, treatment status, or symptoms like fatigue.
Specimen: 2-5 mL whole blood (EDTA), 2-4 mL plasma (EDTA), or 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, liver pain, or history of chronic hepatitis B. Include current medications, especially antivirals, and treatment history.
Consent: Written consent required, detailing the tests purpose, monitoring implications, and potential need for treatment adjustments.
Procedural Considerations: Uses PCR to quantify HBV DNA levels. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Improper sample handling, contamination, or low viral load can affect results. Antiviral therapy may suppress DNA levels.
Clinical Significance: Declining HBV DNA levels indicate treatment response, guiding therapy continuation. High levels suggest resistance or poor response, prompting adjustments.
Specialist Consultation: Consult a hepatologist for result interpretation and antiviral therapy planning.
Additional Supporting Tests: HBsAg, anti-HBc, or liver function tests to monitor hepatitis B status.
Test Limitations: Low viral loads may be undetectable. Clinical correlation and serial testing are needed.
References: AASLD Hepatitis B Guidelines, 2023; Hepatology, Lok AS, 2022.
